DESIGN AND EVALUATION OF COLON SPECIFIC DRUG DELIVERY OF BUDENOSIDE

Abstract

Objective: The objective of this research is to design and evaluate a colon specific drug delivery of budenoside using guar gum as enzyme dependent polymer.Methods: Matrix tablets of Budenoside were prepared by using wet granulation technique with different proportions of guar gum and evaluated for different evaluation tests and release profiles.Results: The formulations were studied for post compression parameters like hardness, friability, weight variation and drug content are in acceptable range of pharmacopoeial specifications. In vitro swelling and Invitro release studies was carried out at different pH ranges (1.2, 6.8 and 7.4). The release profile of budenoside from the matrix tablets is dependent upon the gelling property of guar gum and degradation of guar gum polysaccharide by colonic bacteria. High concentration of guar gum showed less drug release in the stomach as an enzyme dependent polymer. In vitro release data revealed that the presence of rat caecal content in dissolution medium showed the significant increase in drug release (97.12%), when compared to drug release study in absence of caecal content (76.86).Conclusion: The results were subjected to study the release kinetics. The values of correlation coefficient indicated that the drug release followed Zero order drug release kinetics with Peppas drug release mechanism. In vitro drug release studies shows that guar gum with high concentration (25%) has optimum release in a controlled manner for 24 hours. 

Authors and Affiliations

K Vivekanandan, V. Gunasekaran, G. Jayabalan

Keywords

Related Articles

SYNTHESIS OF NOVEL CYCLOHEXANONE DERIVATIVES AS BCR-ABL T1351 INHIBITORS

Objective: Several 3(rd) generation inhibitors are being developed for the treatment of patients with Chronic myelogenous leukemia (CML). The present work mainly aims to discover novel small molecular inhibitors against...

ENHANCED TRANSDERMAL PERMEABILITY OF TELMISARTAN BY A NOVEL NANOEMULSION GEL

Objective: Telmisartan is an angiotensin II type I receptor blocker antihypertensive agent with 42% oral bioavailability. The aim of the present investigation was to develop a nanoemulsion gel to enhance bioavailability...

BARLERIA MONTANA WIGHT AND NEES–A PROMISING NATURAL ANTI-INFLAMMATORY AGENT AGAINST FORMALIN INDUCED INFLAMMATION

Objective: To evaluate the anti-inflammatory activity of the ethanolic leaf extract of Barleria montana (B. montana) against formalin induced inflammation.Methods: Male albino wistar rats were pretreated with oral doses...

QUANTITATIVE DETERMINATION AND PREPARATIVE ISOLATION OF TWO MAJOR ALKALOIDS FROM THE VIETNAMESE MEDICINAL HERB EVODIAE FRUCTUS

Objective: To develop a simple and accurate HPLC-DAD method for simultaneous determination, the content of major components: limonin, evodiamine, and rutaecarpine in Evodiae fructus and evaluation the quality of Evodiae...

DETERMINATION, ISOLATION, AND IDENTIFICATION OF AUCUBIN AND VERBASCOSIDE IN THE LEAVES OF IRAQI PLANTAGO LANCOLETA L. USING DIFFERENT DETECTING METHODS

Objective: Plantago lanceoleta L. (ribwort plantain) is one of the important medicinal herbs which is widespread fortune available in Iraq, that have a wide range of medicinal properties. The aim of this work was to dete...

Download PDF file
  • EP ID EP579201
  • DOI -
  • Views 106
  • Downloads 0

How To Cite

K Vivekanandan, V. Gunasekaran, G. Jayabalan (2015). DESIGN AND EVALUATION OF COLON SPECIFIC DRUG DELIVERY OF BUDENOSIDE. International Journal of Pharmacy and Pharmaceutical Sciences, 7(1), 261-263. https://europub.co.uk/articles/-A-579201